These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3693386)

  • 1. Controlled release using a new bioerodible polyphosphazene matrix system.
    Laurencin CT; Koh HJ; Neenan TX; Allcock HR; Langer R
    J Biomed Mater Res; 1987 Oct; 21(10):1231-46. PubMed ID: 3693386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of side group chemistry on the properties of biodegradable L-alanine cosubstituted polyphosphazenes.
    Singh A; Krogman NR; Sethuraman S; Nair LS; Sturgeon JL; Brown PW; Laurencin CT; Allcock HR
    Biomacromolecules; 2006 Mar; 7(3):914-8. PubMed ID: 16529431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miscibility of bioerodible polyphosphazene/poly(lactide-co-glycolide) blends.
    Krogman NR; Singh A; Nair LS; Laurencin CT; Allcock HR
    Biomacromolecules; 2007 Apr; 8(4):1306-12. PubMed ID: 17338563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biologically relevant properties of polyphosphazene polyacids.
    Andrianov AK; Svirkin YY; LeGolvan MP
    Biomacromolecules; 2004; 5(5):1999-2006. PubMed ID: 15360316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocompatibility evaluation of poly(glycine ethyl ester-co-alanine ethyl ester)phosphazene with honeycomb-patterned surface topography.
    Duan S; Yang X; Mao J; Qi B; Cai Q; Shen H; Yang F; Deng X; Wang S
    J Biomed Mater Res A; 2013 Feb; 101(2):307-17. PubMed ID: 22733644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo biodegradability and biocompatibility evaluation of novel alanine ester based polyphosphazenes in a rat model.
    Sethuraman S; Nair LS; El-Amin S; Farrar R; Nguyen MT; Singh A; Allcock HR; Greish YE; Brown PW; Laurencin CT
    J Biomed Mater Res A; 2006 Jun; 77(4):679-87. PubMed ID: 16514601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.
    Andrianov AK; Marin A; Roberts BE
    Biomacromolecules; 2005; 6(3):1375-9. PubMed ID: 15877355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and optimization of methylphenoxy substituted polyphosphazene nanofibers for biomedical applications.
    Nair LS; Bhattacharyya S; Bender JD; Greish YE; Brown PW; Allcock HR; Laurencin CT
    Biomacromolecules; 2004; 5(6):2212-20. PubMed ID: 15530035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
    Frank A; Rath SK; Venkatraman SS
    J Control Release; 2005 Feb; 102(2):333-44. PubMed ID: 15653155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile preparation of fluorescent particles based on polyphosphazenes: from micro- to nanoscale.
    Zhang J; Qiu L; Li X; Jin Y; Zhu K
    Small; 2007 Dec; 3(12):2081-93. PubMed ID: 18034440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low temperature formation of hydroxyapatite-poly(alkyl oxybenzoate)phosphazene composites for biomedical applications.
    Greish YE; Bender JD; Lakshmi S; Brown PW; Allcock HR; Laurencin CT
    Biomaterials; 2005 Jan; 26(1):1-9. PubMed ID: 15193876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(imidazole/DMAEA)phosphazene/DNA self-assembled nanoparticles for gene delivery: synthesis and in vitro transfection.
    Yang Y; Xu Z; Jiang J; Gao Y; Gu W; Chen L; Tang X; Li Y
    J Control Release; 2008 May; 127(3):273-9. PubMed ID: 18346807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
    Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
    J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, and osteocompatibility evaluation of novel alanine-based polyphosphazenes.
    Nair LS; Lee DA; Bender JD; Barrett EW; Greish YE; Brown PW; Allcock HR; Laurencin CT
    J Biomed Mater Res A; 2006 Jan; 76(1):206-13. PubMed ID: 16265637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly[(amino acid ester)phosphazenes] as substrates for the controlled release of small molecules.
    Allcock HR; Pucher SR; Scopelianos AG
    Biomaterials; 1994 Jun; 15(8):563-9. PubMed ID: 7948574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen.
    Caliceti P; Lora S; Marsilio F; Veronese FM
    Farmaco; 1995 Dec; 50(12):867-74. PubMed ID: 8634078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically crosslinkable thermosensitive polyphosphazene gels as injectable materials for biomedical applications.
    Potta T; Chun C; Song SC
    Biomaterials; 2009 Oct; 30(31):6178-92. PubMed ID: 19709738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate.
    Song R; Joo Jun Y; Ik Kim J; Jin C; Sohn YS
    J Control Release; 2005 Jun; 105(1-2):142-50. PubMed ID: 15894394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.